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Abstract: 
Objective: Anticoagulation reversal, intensive blood pressure lowering, neurosurgery 
and access to critical care might all be beneficial in acute intracerebral hemorrhage 
(ICH).  We combined and implemented these as the ‘ABC’ hyperacute care bundle 
and sought to determine whether the implementation was associated with lower case 
fatality. 
Methods: The ABC bundle was implemented from 1 June 2015 to 31 May 2016. Key 
process targets were set and a registry captured consecutive patients. We compared 
30-day case fatality before, during and after bundle implementation with multivariable 
logistic regression and used mediation analysis to determine which care process 
measures mediated any association. Difference-in-difference analysis compared 30-
day case fatality with 32,295 patients with ICH from 214 other hospitals in England 
and Wales using Sentinel Stroke National Audit Programme data.  
Results: 973 ICH patients were admitted in the study period. Compared to before 
implementation, the adjusted odds of death by 30 days were lower in the 
implementation period (odds ratio [OR] 0·62; 95% confidence interval [CI] 0·38 to 
0·97; p=0·03) and this was sustained after implementation (OR 0·40; 95%CI: 0·24 to 
0·61; p<0·0001). Implementation of the bundle was associated with a 10·8 pp 
(95%CI -17·9 to -3·7; p=0·003) reduction in 30-day case fatality in difference-in-
difference analysis. The total effect of the care bundle was mediated by a reduction 
in do-not-resuscitate orders within 24 h (52·8%) and increased admission to critical 
care (11·1%). 
Interpretation: Implementation of the ABC care bundle was significantly associated 
with lower 30-day case fatality after ICH.  
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Introduction:  
Intracerebral hemorrhage (ICH) has the worst outcomes of all stroke sub-types, with 
a case-fatality at one month of 30 to 40% and only 20% regaining independence.1 
Globally, hemorrhagic stroke accounts for 49% of 6·5 million annual stroke deaths 
and 58% of disability adjusted life years lost to stroke.2 Despite this substantial 
health burden, there are few effective treatments and this may lead to pessimism 
amongst clinicians when managing ICH patients.3 
 
Improving the implementation of existing evidence-based and guideline-
recommended interventions might lead to improved outcomes. 10 to 20% of acute 
ICH occurs in patients taking oral anticoagulants and this is associated with a high 
risk of early hematoma expansion.4,5 Rapid treatment to normalize coagulation 
reduces this risk and might improve outcomes.5,6 Intensive blood pressure (BP) 
lowering within six hours of onset to a target systolic BP (SBP) of 130 to 140 mmHg 
was shown to reduce disability and improve quality of life at 90 days in a pre-
specified secondary analysis of the INTERACT2 trial, but this intervention can be 
challenging to implement.7 Neurosurgery to evacuate the hematoma or treat 
hydrocephalus might improve outcome but no single randomized controlled trial has 
been positive and who to operate on and when remains uncertain. An individual 
patient data meta-analysis of trials of early hematoma evacuation for supratentorial 
ICH shows patients with larger hematomas (20 to 50 ml) and with reduced 
consciousness but who are not comatose (Glasgow Coma Scale [GCS] score 9 to 
12) might to benefit from hematoma evacuation.8 Surgery for cerebellar ICH is widely 
recommended and associated with lower mortality,9 but has not been tested in a 
randomized controlled trial. 
 
Whether effective delivery of these interventions together improves survival is 
unknown. We aimed to evaluate the implementation of a care bundle combining 
these interventions (The ‘ABC’ care bundle) on case fatality rates for patients with 
acute ICH. We considered individual patient randomization to be unethical and not 
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feasible and so conducted the study in the setting of a quality improvement program 
at a large Comprehensive Stroke Centre in the United Kingdom. Using data from 
detailed local and national clinical registries, including data from all stroke centers in 
England, we sought to use quasi-experimental methods to evaluate the impact of the 
care bundle on 30-day case fatality in patients with ICH and to determine the 
contribution of individual bundle components to any overall treatment effects.   
Methods: 
Intervention:  
The Acute Bundle of Care for Intracerebral Hemorrhage (ABC-ICH) project ran from 
1 June 2015 to 31 May 2016 at Salford Royal NHS Foundation Trust, a large 
Comprehensive Stroke Centre and regional Neurosurgical Centre in Greater 
Manchester, UK. A multidisciplinary team of stroke physicians, neurosurgeons, 
stroke nurses and managers contributed to the project with support from a local 
innovation and improvement science center through a program of three 3-day 
workshops, monthly webinars, improvement coaching and site visits. The ABC-ICH 
project aim was to reduce 30-day case fatality after acute ICH through consistent 
and effective delivery of the ‘ABC’ acute care bundle. The ABC care bundle 
comprises evidence-based interventions recommended in the American Stroke 
Association ICH guidelines10 and the Royal College of Physicians National Clinical 
Guideline for Stroke,11 and we set the following process targets:   
A. Rapid anticoagulant reversal, with delivery of four-factor prothrombin complex 
concentrate (PCC) for vitamin-K antagonists and anti-Xa antagonists or 
idarucizumab for dabigatran within 90 min of arrival. 
B. Delivery of intensive blood pressure lowering to an SBP target of 130-140 
mmHg for patients arriving within 6 h of onset with an SBP over 150 mmHg. 
We aimed for a needle-to-target time (NTT; time from the first dose of an 
intravenous antihypertensive to achieving target SBP) of < 60 min. 
C. Adherence to a care pathway prompting immediate neurosurgical referral of 
all patients with good pre-morbid function (modified Rankin Scale [mRS] score 
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≤ 2) and any of: GCS < 9; posterior fossa ICH; an obstructed 3rd/4th ventricle; 
hematoma volume > 30 ml (measured by the ABC/2 method12). 
Improvements in ABC care bundle delivery were achieved through engagement of 
senior leaders, training and education including simulations, audit and feedback to 
clinical teams, and plan-do-study-act (PDSA) cycles to improve care processes. We 
made changes to improve speed of anticoagulation reversal prior to the period of 
data collection for the ABC-ICH project, including the use of point-of-care 
coagulation testing, a supply of PCC in the Emergency Department and a protocol to 
proceed with treatment without hematology referral.13 Key changes to optimize 
intensive blood pressure lowering were the introduction of a standard protocol with a 
clear treatment escalation policy, the introduction of first-line, nurse-led treatment 
with intravenous glyceryl trinitrate and the provision of a one-page quick reference 
sheet. The care pathway was facilitated by engagement with senior clinicians in 
neurosurgery and critical care. 
 
Measurement:  
A clinical registry was established on 1 June 2015, including all consecutive patients 
with spontaneous ICH admitted to Salford Royal Hospital between 1 June 2013 and 
31 May 2017. Patients with traumatic ICH, hemorrhagic transformation of ischemic 
stroke and primary subdural or subarachnoid hemorrhage were excluded. Baseline 
characteristics, clinical presentation, acute care processes, clinical observations and 
diagnostic brain imaging characteristics were extracted from the electronic patient 
record (EPR) for entry into the registry. We collected whether patients were admitted 
directly to Salford Royal Hospital, transferred from elsewhere, or had their ICH as an 
in-patient. Brain scans were reviewed by experienced stroke clinicians to determine 
ICH location, intraventricular hemorrhage and hematoma volume using the ABC/2 
method.12 We reviewed multiple overlapping databases to ensure complete case 
ascertainment including clinical coding, neurosurgical referral database and national 
quality registry data, all of which were established and operational throughout the 
period of data collection. Time periods were defined as ‘before implementation’ (1 
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June 2013 to 31 May 2015), ‘implementation’ (1 June 2015 to 31 May 2016) and 
‘after implementation’ (1 Jun 2016 to 31 May 2017). Key process data were 
prospectively entered and regularly reviewed at team meetings from 1 June 2015. 
 
Outcomes and hypotheses: 
The primary outcome was 30-day all-cause case fatality. In-hospital and post-
discharge deaths were ascertained by data linkage between the hospital EPR and 
the national statutory register of patient deaths. A survival check was performed for 
all cases on 5 October 2017, giving a minimum of 5 months follow-up. Secondary 
outcomes were key process and care measures and included door-to-needle time 
(DNT) for anticoagulation reversal, needle-to-target time (NTT) for intensive blood 
pressure lowering, percentage of patients undergoing neurosurgery within 72 h of 
arrival, percentage of patients with a do-not-resuscitate (DNR) order within 24 h of 
arrival in hospital, and percentage of patients admitted to critical care (high 
dependence unit [HDU] or intensive care unit [ICU]) within 72 h of arrival. Our 
primary hypothesis was that implementation of the acute care bundle would be 
associated with a significant reduction in 30-day case fatality during the 
implementation period compared to the period before implementation at our center 
and contemporary data from the rest of England and Wales. Our secondary 
hypothesis was that in addition to improving relevant process targets, 
implementation of the care bundle would lead to enhanced supportive care, as 
measured by more admissions to higher level care and fewer DNR orders within 24 
h of admission. 
 
Statistical analysis: 30-day case fatality for patients admitted to Salford with ICH was 
compared between time periods using Kaplan-Meier analysis with the logrank test 
for statistical significance. Process and care measures were compared between time 
periods using the Kruskal-Wallis test. We fitted multivariable logistic regression 
models to compare 30-day case fatality between time periods, adjusting for key 
prognostic factors in ICH. A quasi-experimental analysis used difference-in- 
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difference analysis to compare the change in 30-day case fatality rates before and 
after the bundle implementation with data from the national quality registry of stroke 
(the Sentinel Stroke National Audit Programme; SSNAP).  This was done to provide 
additional control against unmeasured confounders and to control for secular 
improvements in stroke outcomes unrelated to the intervention. Data from SSNAP 
included data on patients with ICH admitted to all stroke centers in England and 
Wales during the study period. Model-based causal mediation analysis14,15 was 
performed to determine the average causal mediation effects for the care and 
process measures that changed as part of the implementation of the care. The 
proportion mediated is reported for the parts of the care bundle that were significant 
in improving the 30-day case fatality. The study was approved by the Health 
Research Authority (Ref: 18/HRA/0384). 
 
Role of the funding source: Dr Parry-Jones is supported by an NIHR Clinician 
Scientist Award and the implementation science training program was delivered by 
Haelo and funded by the Manchester Academic Health Sciences Centre. The 
funders had no role in the design or conduct of the study; the collection, 
management, analysis, or interpretation of the data; the preparation, review, or 
approval of the manuscript; or the decision to submit the manuscript for publication. 
 
Results: 
973 patients were captured in the Salford ICH registry during the study period 
(Figure 1). Because they could not have benefited from the acute care bundle, we 
excluded all patients where a decision was made restrict care to palliation only within 
one hour of arrival in hospital (n=66) or who were not under the care of stroke or 
neurosurgery during their admission (n=44). In addition, patients with missing data 
were removed (n=3) leaving 353 in the before implementation group, 266 in the 
implementation group and 241 in the after implementation group. There were no 
statistically significant differences in baseline clinical and imaging characteristics 
between the groups before (Table 1) and after (Table 2) excluding palliated patients 
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or those under other specialties. Compared to the before implementation period, 
unadjusted 30-day case fatality fell significantly in the implementation period (21·4% 
vs. 27·8%, p=0·07) and this benefit was sustained in the after implementation period 
(15·4% vs. 27·7%, p<0·001; Figure 2). After adjusting for pre-morbid mRS, level of 
consciousness on arrival, infratentorial hemorrhage, age, IVH, ICH volume and 
anticoagulant use, patients in the intervention period had a lower odds of 30-day 
case-fatality (OR 0·62, 0·38 to 0·97, p=0·003). This was sustained in the after 
implementation period (OR 0·40, 0·24 to 0·61, p<0·0001; Table 3). We repeated 
these analyses for all ICH patients, including patients where a decision was made to 
restrict care to palliation only within one hour of arrival in hospital and those who 
were not under the care of stroke or neurosurgery during their admission. For this 
sensitivity analysis and in contrast to the primary analysis, time from onset-to-arrival 
was significantly associated with death by 30 days (OR 0.99, 0.97 to 1.00; p=0.03) 
so was included in the multifactorial model. With all patients now included, admission 
during the implementation period was no longer significantly associated with a 
reduced odds of death by 30 days (OR 0·69, 0·42 to 1.06, p=0·09) but admission 
after implementation remained strongly significantly associated with a reduced odds 
of death by 30 days (OR 0·41, 0·24 to 0·63, p<0·0001). The quasi-experimental 
difference-in-difference analysis included 32,295 patients with ICH from 214 other 
hospitals in England and Wales. This demonstrated a 10·8 pp (95%CI -17·9 to -3·7; 
p = 0·003) absolute reduction in 30-day case fatality associated with the 
implementation of the care bundle (Figure 3). 
 
Changes to improve DNT for anticoagulant reversal had been made prior to 1 June 
2013.13 No significant change in the median DNT was thus noted (Table 4) between 
the before implementation (132·0 min, IQR: 93·5 to 162·5 min) and implementation 
period (152·5 min, IQR: 87·0 to 210·2 min), but improvements were noted during the 
after implementation period (105·5 min, IQR: 75·5 to 200·5 min). During the 
implementation period (vs. before implementation), more eligible patients received 
intravenous anti-hypertensive drugs to lower acute BP (86% versus 55%, p<0·0001) 
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and for eligible patients receiving intravenous antihypertensive drugs, the median 
NTT markedly improved (43 minutes versus 383 minutes; p <0·0001). The median of 
each patient’s mean SBP over 72 h was lower in the implementation (152.8 mmHg, 
IQR: 145.4 to 163.5 mmHg) and after implementation groups (152.2 mmHg, IQR: 
145.6 to 162·3), compared to before implementation (166.7 mmHg, IQR: 158.3 to 
174.4). No significant difference was observed before and after implementation in 
the variability of SBP over 72 h, as measured by the standard deviation of each 
patients SBP recordings. Supportive care improved in both the implementation and 
after implementation period, with more patients being admitted to HDU (18/347 
[5·2%] before implementation; 32/266 [12·0%] implementation; 25/243 [10·4%] after 
implementation) and less use of DNR orders within 24 h (96/351 [27·4%] before 
implementation; 47/266 [17·7%] implementation; 38/243 [15.8%] after 
implementation). During the after implementation period, but not the implementation 
period, more eligible patients underwent neurosurgery (16/40 [40·0%] before 
implementation; 20/54 [37·0%] implementation; 19/28 [67·9%] after implementation).  
 
Model-based mediation analysis gives an understanding of how the components of 
the care bundle individually contributed to the overall effect. The total effect is 
decomposed into two components: the natural direct effect (NDE) and the natural 
indirect effect (NIE). A significant NIE suggests that the process mediated the overall 
effect. The mediation analysis (Table 5) demonstrated that the observed reduction in 
DNR orders within 24 h mediated 52·8% of the association between care bundle 
implementation and lower 30-day case fatality and increased admission to HDU 
mediated 11·1%. As DNT for anticoagulation reversal was not significantly lower 
after implementation it could not have been a mediating factor. Although all improved 
after bundle implementation, time from onset to surgery, intensive blood pressure 
lowering, NTT and change in SBP from arrival to 4 h after arrival were not significant 
mediating factors. As a sensitivity analysis, we repeated the mediation analysis for 
all patients admitted during the study period, including patients where a decision was 
made to restrict care to palliation only within one hour of arrival in hospital and those 
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who were not under the care of stroke or neurosurgery during their admission. Again, 
only access to HDU and DNR within 24 h were significant mediators, mediating 
12.5% and 56.0% of the overall association, respectively.  
 
Discussion: 
Within the setting of an active quality improvement program to improve acute care 
for patients with ICH, implementation of the ABC bundle was associated with 
improved delivery of intensive blood pressure lowering, better access to 
neurosurgery, improved supportive care, and a relative reduction in 30-day case 
fatality of over a third, which was not accounted for by case-mix or secular national 
trends. These improvements in care and survival were sustained for the year 
following the ABC-ICH project. This study supports the hypothesis that consistent 
and effective delivery of evidence-based, guideline-recommended care to acute ICH 
patients may lead to a marked improvement in survival, suggesting that existing 
therapeutic nihilism3 may no longer be justified. We have shown that a 
comprehensive implementation strategy comprising executive and senior leader 
support, multidisciplinary working, continuous audit and feedback, PDSA cycles, 
education and simulation training was effective in introducing, delivering and 
sustaining the ABC bundle in the setting of a Comprehensive Stroke Centre. 
 
Prior to the ABC-ICH project, we improved DNT for anticoagulant reversal13 and this 
did not improve further during the implementation period. Although this means it 
cannot have contributed significantly to the observed reduction in case fatality, there 
is both observational and clinical trial data to suggest that prompt reversal of 
anticoagulation improves survival,4–6 making it an important component of the ABC 
care bundle. Marked improvements were made in the delivery of intensive BP 
lowering and our finding that this did not mediate improved survival is consistent with 
the findings of the INTERACT2 trial, in which the intervention reduced disability and 
improved quality of life but did not improve survival. Our care pathway was based on 
existing evidence8,16 and guidleines10,11 and was associated with a significant 
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increase in the percentage of eligible patients undergoing acute neurosurgery. 
Although neurosurgery was not a significant mediator of the associated reduction in 
case fatality, this may be attributable to low statistical power as only 6.4% of patients 
underwent surgery overall. While not explicitly part of the ABC care bundle, we found 
that more patients were admitted to HDU and less had a DNR order within 24 h or 
arrival once the care bundle was implemented. This suggests that a cultural shift 
towards a less nihilistic approach to ICH care occurred, perhaps as an indirect effect 
of ABC care bundle implementation. Our mediation analysis suggests that over half 
of the association between improved survival and implementation of the care bundle 
is attributable to this reduction in early DNR orders, with a smaller percentage 
attributable to HDU admission. In support of this finding, a previous prospective, 
observational, cohort study demonstrated that up to a third of ICH patients with a 
GCS ≤ 12 make a good recovery if DNR orders were limited, contrary to predictions 
based on severity grading scales, such as the ICH score.17,18 
 
Our study has some limitations. Firstly, the study design prevents us from making 
firm conclusions regarding a causal relationship between the ABC care bundle and 
lower case fatality, even though the use of the quasi-experimental difference-in-
difference methodology provides support for a causal effect. Further testing in a 
cluster-randomized trial will be required to definitively test our study hypotheses. 
Secondly, we did not have sufficient resources to measure longer-term disability (for 
example, mRS score at 6 months). We do not therefore know what impact the 
bundle had on the disability profile in survivors. Our hypothesis is that the care 
bundle will lead to a shift towards improved outcome across the entire range of mRS, 
a composite outcome of death and disability. For example, it may be that patients 
who would have died from their ICH will survive with severe disability, but also those 
that would have survived with severe disability without the bundle will survive with 
mild or moderate disability instead. The evidence underpinning the care processes 
changed by the care bundle supports this. The INTERACT2 trial demonstrated a 
reduction in disability across the entire range of the mRS.7 Rapidly reversing 
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anticoagulation will prevent small hematomas expanding,5,6 thus preventing mild-
moderate strokes deteriorating to severe strokes or death. Individual patient data 
meta-analysis of trials of hematoma evacuation has shown a reduction in 
‘unfavorable outcome’ (defined as death plus the vegetative state or severe 
disability) with surgery in the patients we are targeting with our care pathway.8 A 
multicenter prospective observational study has tested a policy of avoiding DNR 
orders in first 5 days of care in a subgroup of patients with severe ICH (defined as 
Glasgow Coma Scale [GCS] score ≤ 12).17 30-day case fatality was predicted to be 
50% but was observed to be 20·2%. At 90 days, 27·1% had died, 21·5% had severe 
disability, 29·9% had moderately severe disability, but a better recovery (mRS 0-3) 
was achieved by 29·9%. In other words, in this group of severe ICH that most 
clinicians would consider to have a poor prognosis, nearly a third made a good 
recovery. Thirdly, changes were made to the centralized stroke pathway in Greater 
Manchester in March 2015 that might be expected to impact on ICH care and 
outcomes. The time window from symptom onset for diverting patients to one of the 
three hyperacute stroke units (HASUs) changed from 4 h to 48 h and once admitted 
patients remained at the HASU for 72 h, compared to 24 h before the reorganization.  
We have shown that the ICH case mix did not change during the study period (Table 
2), suggesting that the ABC-ICH project and not the pathway reorganization 
accounted for the changes observed at Salford. 
 
In summary, ICH is a major cause of death and disability worldwide and we present 
evidence suggesting that simple strategies to consistently and effectively deliver our 
ABC care bundle might lead to an improvement in survival. Further evaluation of the 
ABC care bundle in a cluster randomized trial is needed to establish clinical and cost 
effectiveness, including a measure of later disability as the primary outcome. If 
proven to be effective in prospective trials, implementation of the ABC care bundle 
could significantly reduce the substantial morbidity and mortality associated with this 
otherwise severe subtype of stroke.  
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Figure legends: 
Figure 1: Summary of patients admitted before, during and after bundle 
implementation 
 
Figure 2: Survival after acute ICH at Salford Royal Hospital: Kaplan-Meier curve 
showing survival for first 30 days after admission during the before implementation 
(solid line), implementation (dashed line) and after implementation (dotted line) 
periods. Survival was more likely in the implementation and after implementation 
periods (p<0·001; logrank test). 
 
Figure 3: Difference-in-difference analysis: Salford Royal Hospital (circles) 
compared to the rest of England and Wales (crosses, n=32,295). Points signify 30-
day case fatality for patients admitted during each 2-month period from 1 Jun 2013 
to 31 May 2017.  A regression line for each group (Salford Royal Hospital, solid line; 
rest of England and Wales, dashed line) before and after bundle implementation 
from 1 Jun 2015 was fitted. 
  
This article is protected by copyright. All rights reserved.
   
Table 1: Baseline characteristics for all consecutive Salford Royal Hospital 
acute ICH patients: Columns represent time periods in relation to ABC care bundle 
implementation; before implementation (1 Jun 2013 to 31 May 2015), 
implementation (1 Jun 2015 to 31 May 2016), and after implementation (1 Jun 2016 
to 31 May 2017). Patients palliated on admission and/or not admitted under stroke or 
neurosurgery are included. All data are presented as median and interquartile range, 
unless otherwise stated. Where data are missing, the number of complete cases is 
shown as the denominator or the number missing is indicated. GCS=Glasgow Coma 
Scale, ICH=intracerebral haemorrhage, IVH=intraventricular haemorrhage, 
mRS=modified Rankin Scale, SBP=systolic blood pressure. 
 
Factor 
Before 
implementation 
(n=403) 
Implementation (n=303) After implementation (n=267) p 
Age 71·5 (57.1 – 81·2) 69·5 (55·2 – 80·0) 72.8 (61.0 – 81.1) 0·09 
Premorbid mRS (0-2); 
n(%) 321 (79.7%) 243 (80.2%) 231 (86.5%) 0·06 
Anticoagulant; n(%) 56 (13.9%) 43 (14.2%) 34 (12.7%) 0·87 
Sex (female); n(%) 213 (52·9%) 147 (48·5%) 149 (55.8%) 0·21 
GCS 14 (10-15) 14 (10-15) 14 (10-15) 0·82 
Route of arrival; n(%) 
Direct 315 (78.2%) 
Transfer 67 (16.6%) 
In-patient 8 (2.0%) 
Other 13 (3.2%) 
Direct 194 (64.0%) 
Transfer 83 (27.4%) 
In-patient 8 (2.6%) 
Other 18 (5.9%) 
Direct 167 (62.5%) 
Transfer 84 (31.5%) 
In-patient 3 (1.1%) 
Other 13 (4.9%) 
P<0.0001 
Palliated on 
admission; n(%) 40 (9·9%) 22 (7.3%) 13 (4·9%) 0·05 
SBP on admission 169 (148-200) 166 (144-193) 163 (142-189) 0·06 
Infratentorial; n(%) 51 (12·7%) 38 (12·5%) 33/265 (12.5%) 0·99 
IVH; n(%) 157/402 (39.1%) 122 (40.3%) 95/265 (35.8%) 0·54 
ICH volume (ml) 17·6 (5.9 – 51.1) 1 missing 16.6 (5·0 – 46·1) 
19·5 (6·3 – 48·9) 
2 missing 0·53 
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Table 2: Baseline characteristics for Salford Royal Hospital acute ICH patients 
admitted under Stroke Medicine or Neurosurgery and not palliated on 
admission: Columns represent time periods in relation to ABC care bundle 
implementation; before implementation (1 Jun 2013 to 31 May 2015), 
implementation (1 Jun 2015 to 31 May 2016), and after implementation (1 Jun 2016 
to 31 May 2017). Patients palliated on admission and/or not admitted under stroke or 
neurosurgery were excluded. All data are presented as median and interquartile 
range, unless otherwise stated. All fields were complete for all patients. 
GCS=Glasgow Coma Scale, ICH=intracerebral hemorrhage, IVH=intraventricular 
hemorrhage, mRS=modified Rankin Scale, SBP=systolic blood pressure. 
Factor 
Before 
implementation 
(n=353) 
Implementation (n=266) After implementation (n=241) p 
Age 69·8 (55·6 – 80·1) 68·5 (53·7 – 79·8) 71·2 (59·6 – 80·3) 0·11 
Premorbid mRS (0-2); 
n(%) 286 (81·0%) 220 (82·7%) 212 (88·0%) 0·08 
Anticoagulant; n(%) 47 (13·3%) 36 (13·5%) 29 (12.0%) 0·86 
Sex (female); n(%) 186 (52·5%) 128 (48·1%) 127 (52·7%) 0·46 
GCS 14 (11-15) 14 (11-15) 14 (11-15) 0·45 
Route of arrival; n(%) 
Direct 281 (79.6%) 
Transfer 65 (18.4%) 
In-patient 7 (2.0%) 
Direct 177 (66.5%) 
Transfer 83 (31.2%) 
In-patient 6 (2.3%) 
Direct 158 (65.6%) 
Transfer 81 (33.6%) 
In-patient 2 (0.8%) 
P<0.0001 
SBP on admission 168 (150 - 198) 165 (144 - 193) 162 (141 - 188) 0·09 
Infratentorial 
hemorrhage; n(%) 37 (10·5%) 32 (12·0%) 28 (11·6%) 0·82 
Intraventricular 
hemorrhage; n(%) 124 (35·1%) 98 (36·8%) 79 (32·8%) 0·63 
ICH volume (ml) 14·0 (5·4 – 38·5) 15·3 (5·0 – 42·3) 18·4 (5·9 – 42·3) 0·41 
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Table 3: Factors associated with death by 30-days after admission with acute 
ICH at Salford Royal Hospital: Results of a multivariable logistic regression model 
testing the association between admission period (before implementation, 
implementation, after implementation) and death by 30-days, adjusting for key ICH 
prognostic indicators. Onset-to-arrival time and route of arrival (direct admission, 
transfer, inpatient stroke) were not significant so were excluded from the model. 
GCS=Glasgow Coma Scale, ICH=intracerebral hemorrhage, IVH=intraventricular 
hemorrhage, mRS=modified Rankin Scale. 
 
Odds Ratio Lower CI Upper CI P-value 
Premorbid mRS  (vs. 0) 
    
1 0·84 0·41 1·42 0·50 
2 1·90 0·92 3·33 0·08 
3 3·13 1·70 5·34 <0·0001 
4 3·04 1·28 5·98 0·01 
5 2·46 0·32 9·30 0·85 
Age 1·06 1·04 1·08 <0·0001 
GCS at arrival 0·82 0·77 0·87 <0·0001 
Infratentorial (vs· supra) 2·05 1·10 3·43 0·02 
IVH 2·03 1·35 3·00 <0·0001 
ICH volume 1·02 1·02 1·03 <0·0001 
Taking anticoagulants 1·74 1·05 2·80 0·04 
Implementation period (vs. before 
implementation) 
0·62 0·38 0·97 0·03 
After implementation period (vs. before 
implementation) 
0·40 0·24 0·61 <0·0001 
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Table 4: Process and care measures: Key process and care measures during 
each study period at Salford Royal Hospital. All data are presented as median and 
interquartile range, unless otherwise stated. Where data are missing, the number of 
complete cases is shown as the denominator. DNT=door to needle time, DNR=do-
not-resuscitate, IQR=interquartile range, NTT-needle to target time, SBP=systolic 
blood pressure, SD=standard deviation. 
 
 
Before 
implementation 
(n=353) 
Implementation 
(n=266) 
After implementation 
(n=241) p 
DNT (min) 132·0 (93·5-162·5) 152·5 (87·0-210·2) 105·5 (75·5-200·5) 0·65 
Intravenous 
antihypertensive (n, number 
eligible, % of eligible) 
94/172 (54.7) 70/82 (85.4) 58/69 (84.1) <0·0001 
NTT (min) 383·0 (219·5-924·5) 43.0 (27.5-75·0) 50·0 (35·0-65·0) <0·0001 
Mean SBP 0-72 h (mmHg) 166.7 (158·3-174·4) 152·8 (145·4-163·5) 152.1 (145·6-162·3) <0·01 
SD of SBP 0-72 h (mmHg) 25.7 (19.3-32.0) 25·0 (19.4-31.7) 25.0 (19·5-29·7) 0·88 
Neurosurgery; (n, number 
eligible, % of eligible) 16/40 (40·0) 20/54 (37·0) 19/28 (67·9) 0·02 
High Dependency Unit; n 
(%) 19 (5·4) 32 (12·0) 25 (10·4) <0·01 
Intensive Care Unit; n (%) 50 (14·2) 47 (17·7) 49 (20·3) 0·14 
DNR < 24 h; n (%) 96 (27·2) 47 (17·7) 38 (15·8) <0·001 
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Table 5: Mediation analysis: Results of analysis to determine factors mediating the 
association between bundle implementation and 30-day survival. Door-to-
anticoagulant reversal time, intensive BP lowering, door-to-blood pressure target 
time, change in SBP from 0 to 4 h, admission to intensive care unit and neurosurgery 
were not significant mediators  CI=confidence interval, DNR=Do-not-resuscitate 
order, HDU=High Dependency Unit, NDE=natural direct effect, NIE=natural indirect 
effect, SBP=systolic blood pressure. 
 Total Effect NIE NDE 
% 
mediated 
 
Estimate 
(p-value) 95% CI 
Estimate 
(p-value) 95% CI 
Estimate 
(p-value) 95% CI  
Access to HDU -0·0594 (0·01) 
(-0·1104, 
-0·01) 
-0·0070 
(0·03) 
(-0·0164, 
0·00) 
-0·0524 
(0·04) 
(-0·1032, 
0·00) 11·1% 
DNR within 24 h -0·0607 (0·02) 
(-0·1109, 
-0·01) 
-0·0324 
(<0·01) 
(-0·0581, 
-0·01) 
-0·0284 
(0·23) 
(-0·0770, 
0·02) 52·8% 
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Figure1: Summary of patients admitted before, during and after bundle implementation 
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 Figure 2: Survival after acute ICH at Salford Royal Hospital 
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 Figure 3: Difference-in-difference analysis 
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